Registration for this training ended on Mon, 08/19/2019 - 16:00
90-Minute Webinar
Originally aired August 28, 2019
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
This training was intended for TB program staff interested in learning more about the new recommendations on TB screening, testing, and treatment of U.S. Health Care Personnel. This webinar was a collaboration between the Curry Center, the Rutgers Global TB Institute, the National TB Controllers Association (NTCA), and the CDC.
Webinar Materials: https://www.currytbcenter.ucsf.edu/trainings/2019-cdcntca-recommendations-health-care-personnel-hcp-what-tb-programs-need-know-0
YouTube link available here: https://youtu.be/9nZBklG-hyk
CME and CE units are not being offered for this recording and there is no participant evaluation.
Faculty:
Lisa Chen, MD
Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Medical Director/Principal Investigator
Curry International Tuberculosis Center (CITC)
University of California, San Francisco
Lynn Sosa, MD
TB/STD Control Programs Coordinator
Deputy State Epidemiologist
Connecticut Department of Public Health
Wendy Thanassi, MD, MA, MRO
Chief, Occupational Health Service
VA Palo Alto Health Care System
Associate Clinical Professor
Stanford University
Robert W. Belknap, MD
Director, Denver Metro Tuberculosis Program
Denver Health and Hospital Authority
Associate Professor, Division of Infectious Diseases
University of Colorado
Gibril Njie, MPH
Epidemiologist
Division of Tuberculosis Elimination
Centers for Disease Control and Prevention
Neela Goswami, MD, MPH
Medical Officer
Division of Tuberculosis Elimination
Centers for Disease Control & Prevention
United States
2019 CDC/NTCA Recommendations for Health Care Personnel (HCP): What TB Programs Need to Know
2019 CDC/NTCA Recommendations for Health Care Personnel (HCP): What TB Programs Need to Know
Wednesday, August 28, 2019
10:00am - 11:30am Pacific Time
Key Resources:
- MMWR: Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Asosciation and CDC, 2019
- NTCA Provider Guidance: Using the Isoniazid/Rifapentine Regimen to Treat Latent Tuberculosis Infection (LTBI), November 2018
CDC Resources Highlighted during the Webinar:
- Baseline Assessment Form
- FAQs
- Updated Web content